Quick Answer
Marker Therapeutics, Inc. reported Total Assets of $19.07 million for fiscal year 2025.
Marker Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $19.07M | -13.4% |
| 2024 | $22.02M | +28.6% |
| 2023 | $17.13M | -50.2% |
| 2022 | $34.42M | -49.5% |
| 2021 | $68.14M | +49.4% |
| 2020 | $45.61M | -1.6% |
| 2019 | $46.36M | -25.4% |
| 2018 | $62.14M | +1099.6% |
| 2017 | $5.18M | -34.6% |
| 2016 | $7.92M | +19.2% |
| 2015 | $6.65M | +6276.8% |
| 2012 | $104.2K | -66.2% |
| 2011 | $307.9K | +164.5% |
| 2010 | $116.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.73M | +99.2% | +47.2% |
| June 30, 2025 | $14.77M | +26.5% | -13.1% |
| March 31, 2025 | $16.99M | +20.6% | -22.8% |
| December 31, 2024 | $22.02M | +28.6% | +101.9% |
| September 30, 2024 | $10.91M | -44.0% | -6.5% |
| June 30, 2024 | $11.68M | -46.8% | -17.2% |
| March 31, 2024 | $14.09M | -49.6% | -17.7% |
| December 31, 2023 | $17.13M | -50.2% | -12.1% |
- Marker Therapeutics, Inc. showed a decrease of -13.4% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Marker Therapeutics, Inc.’s total assets has grown by 16279.4% (from $116.4 thousand to $19.07 million).
- The most recent figure is from Marker Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: